A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia

Stopped Early termination; Difficulties in enrolling subjects due to the decrease in patients with MRSA bacteremia

Conditions

• MRSA Bacteremia

Interventions

• DRUG: Delpazolid
• DRUG: Vancomycin
• DRUG: Placebo of Delpazolid

Sponsor

LigaChem Biosciences, Inc.